Rosen, national investor counsel, encourages immunitybio, inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action - ibrx

New york , july 4, 2023 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of immunitybio, inc. (nasdaq: ibrx) between may 23, 2022 and may 10, 2023, both dates inclusive (the "class period"). a class action lawsuit has already been filed.
IBRX Ratings Summary
IBRX Quant Ranking